PTGS2 and cardiovascular disorder: In addition, selective COX-2 inhibitors such as celecoxib have been associated with great risk of adverse cardiovascular effects, and aspirin use was associated with a higher risk of major bleeding in individuals without cardiovascular disease (Zheng and Roddick, 2019; Schjerning et al., 2020).